275 related articles for article (PubMed ID: 25617904)
21. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
[TBL] [Abstract][Full Text] [Related]
22. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
Gow R; Koren G; Rieder M; Van Uum S
Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and management of secondary adrenal crisis.
Martel-Duguech L; Poirier J; Bourdeau I; Lacroix A
Rev Endocr Metab Disord; 2024 Jun; 25(3):619-637. PubMed ID: 38411891
[TBL] [Abstract][Full Text] [Related]
24. Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases.
Shen WT; Lee J; Kebebew E; Clark OH; Duh QY
Arch Surg; 2006 Aug; 141(8):771-4; discussion 774-6. PubMed ID: 16924084
[TBL] [Abstract][Full Text] [Related]
25. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
Harbeck B; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
[TBL] [Abstract][Full Text] [Related]
26. Association of adrenal insufficiency with patient-oriented health-care outcomes in adult medical inpatients.
Ebrahimi F; Widmer A; Wagner U; Mueller B; Schuetz P; Christ-Crain M; Kutz A
Eur J Endocrinol; 2019 Dec; 181(6):701-709. PubMed ID: 31581127
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features and diagnosis of secondary adrenal insufficiency followed complex treatment nonpituitary brain tumors].
Yudina AE; Pavlova MG; Sotnikov VM; Yudina AE; Sych YP; Mazerkina NA; Zheludkova OG; Teryaeva NB; Gerasimov AN; Martynova E; Kim EI; Berkovskaya MA
Probl Endokrinol (Mosk); 2019 Nov; 65(5):330-340. PubMed ID: 32202737
[TBL] [Abstract][Full Text] [Related]
28. Increased Hair Cortisol Concentrations and BMI in Patients With Pituitary-Adrenal Disease on Hydrocortisone Replacement.
Staufenbiel SM; Andela CD; Manenschijn L; Pereira AM; van Rossum EF; Biermasz NR
J Clin Endocrinol Metab; 2015 Jun; 100(6):2456-62. PubMed ID: 25816049
[TBL] [Abstract][Full Text] [Related]
29. Current Management and Outcome of Pregnancies in Women With Adrenal Insufficiency: Experience from a Multicenter Survey.
Bothou C; Anand G; Li D; Kienitz T; Seejore K; Simeoli C; Ebbehoj A; Ward EG; Paragliola RM; Ferrigno R; Badenhoop K; Bensing S; Oksnes M; Esposito D; Bergthorsdottir R; Drake W; Wahlberg J; Reisch N; Hahner S; Pearce S; Trainer P; Etzrodt-Walter G; Thalmann SP; Sævik ÅB; Husebye E; Isidori AM; Falhammar H; Meyer G; Corsello SM; Pivonello R; Murray R; Bancos I; Quinkler M; Beuschlein F
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2853-63. PubMed ID: 32424397
[TBL] [Abstract][Full Text] [Related]
30. Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients.
Delle Cese F; Corsello A; Cintoni M; Locantore P; Pontecorvi A; Corsello SM; Paragliola RM
Front Endocrinol (Lausanne); 2020; 11():610904. PubMed ID: 33597926
[TBL] [Abstract][Full Text] [Related]
31. Dual-release hydrocortisone and its benefits on cognitive function and quality of sleep.
Krekeler C; Kropp P; Blacha AK; Rahvar AH; Harbeck B
Endocrine; 2021 Apr; 72(1):223-233. PubMed ID: 33625720
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.
Zueger T; Kirchner P; Herren C; Fischli S; Zwahlen M; Christ E; Stettler C
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1938-42. PubMed ID: 22872686
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life in patients with non-functioning pituitary adenoma: a special focus on hydrocortisone replacement dose.
Wild CM; Stieg M; Stalla GK; Auer MK; Athanasoulia-Kaspar AP
Qual Life Res; 2020 Dec; 29(12):3325-3331. PubMed ID: 32737686
[TBL] [Abstract][Full Text] [Related]
34. [CME: Adrenal Insufficiency].
Fischli S
Praxis (Bern 1994); 2018 Jun; 107(13):717-725. PubMed ID: 29921185
[TBL] [Abstract][Full Text] [Related]
35. Low Impact of Urinary Cortisol in the Assessment of Hydrocortisone Replacement Therapy.
Haas CS; Rahvar AH; Danneberg S; Lehnert H; Moenig H; Harbeck B
Horm Metab Res; 2016 Sep; 48(9):571-4. PubMed ID: 27300473
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of adrenal deficiency: To what issues? By which therapeutic means?].
Reznik Y
Presse Med; 2014 Apr; 43(4 Pt 1):438-43. PubMed ID: 24636680
[TBL] [Abstract][Full Text] [Related]
37. The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience.
Ventura M; Serra-Caetano J; Cardoso R; Dinis I; Melo M; Carrilho F; Mirante A
J Pediatr Endocrinol Metab; 2019 Jul; 32(7):721-726. PubMed ID: 31194685
[TBL] [Abstract][Full Text] [Related]
38. Quantitative targeted GC-MS-based urinary steroid metabolome analysis for treatment monitoring of adolescents and young adults with autoimmune primary adrenal insufficiency.
Kamrath C; Hartmann MF; Wudy SA
Steroids; 2019 Oct; 150():108426. PubMed ID: 31228484
[TBL] [Abstract][Full Text] [Related]
39. Morbidity in patients on long-term steroid replacement therapy.
Druce MR; Akker SA; Chew SL; Drake WM; Grossman AB
Clin Endocrinol (Oxf); 2010 Apr; 72(4):564-6. PubMed ID: 19549248
[No Abstract] [Full Text] [Related]
40. Evaluation of the frequency of adrenal crises and preventive measures in patients with primary and secondary adrenal insufficiency in Switzerland.
Notter A; Jenni S; Christ E
Swiss Med Wkly; 2018; 148():w14586. PubMed ID: 29376554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
